SCHEMBL23233263

SCHEMBL23233263

c1ccc(-c2ccc(N(c3ccccc3-c3ccc4oc5ccccc5c4c3)c3ccccc3-c3ccccc3-c3ccc4ccccc4c3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 2/20 0.35
▸ PLA2G4A P47712 2/20 0.35
▸ MAPT P10636 4/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ HPGD P15428 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ CASP1 P29466 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ PGR P06401 1/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23233231 1.00 PLA2G2A (0.35) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23233244 0.97 PLA2G2A (0.37) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23233234 0.97 PLA2G2A (0.37) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23233240 0.94 PLA2G2A (0.36) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL24965697 0.94 PLA2G2A (0.36) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23233260 0.94 PLA2G2A (0.38) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23233242 0.94 PLA2G2A (0.38) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23232742 0.93 HCRTR1 (0.34) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL23232609 0.93 PLA2G2A (0.39) PLA2G2APLA2G4AMAPTKDM4EHPGD
SCHEMBL24964615 0.93 PLA2G2A (0.39) PLA2G2APLA2G4AMAPTKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed
WO-2021070963-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026162-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, LEF1, MLX PLA2G2A 3282/4885PLA2G4A 3577/4885MAPT 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback